Platelet monoamine oxidase B activity in dementia. A 4-year follow-up

Dementia and Geriatric Cognitive Disorders

Volumn 9, Issue 2, 1998, Pages 74-77

  Gotz M E ^a,d   Fischer, P ^b   Gsell, W ^a   Riederer, P ^a   Streifler, M ^c   Simanyi, M ^c   Muller F ^c   Danielczyk, W ^c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF VIENNA   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Activity; Dementia; Mini Mental State; Monoamine oxidase; Platelet; Time course

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; NEUROTRANSMITTER;

AGED; ARTICLE; CHOLINERGIC NERVE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DEMENTIA; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HUMAN; MALE; MENTAL HEALTH; MONOAMINERGIC NERVE; PRIORITY JOURNAL; THROMBOCYTE;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; BRAIN; COGNITION; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MONOAMINE OXIDASE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0031941329     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017026     Document Type: Article

References (37)

1. Adolfsson R, Gottfries CG, Oreland L, Wiberg A, Winblad B: Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci 1980;27:1029-1034.
2. Smith RC, Ho BT, Kralik P, Vrolis G, Gordon J, Wolff J: Platelet monoamine oxidase in Alzheimer's disease. J Gerontol 1982;37:572-574.
3. Gottfries CG, Adolfsson R, Aquilonius S-M, Carlsson A, Eckernas S-A, Nordberg A, Oreland L, Svennerholm L, Wiberg A, Winblad B: Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol Aging 1983;4:261-271.
4. Alexopoulos GS, Lieberman KW, Young RC: Platelet MAO activity in primary degenerative dementia. Am J Psychiatry 1984;141:97-99.
5. Alexopoulos GS, Young RC, Lieberman KW: Platelet MAO activity in geriatric patients with depression and dementia. Am J Psychiatry 1987;144:1480-1483.
6. Oreland L, Gottfries CG: Brain monoamine oxidase in aging and in dementia of Alzheimer type. Prog Neuropsychopharmacol Biol Psychiatry 1986;10:533-540.
7. Danielczyk W, Streifler M, Konradi C, Riederer P, Moll G: Platelet MAO-B activity and the psychopathology of Parkinson's disease, senile dementia and multi-infarct dementia. Acta Psychiatr Scand 1988;78:730-736.
8. Reinikainen KJ, Paljärvi L, Halonen T, Malminen O, Kosma V-M, Laakso M, Riekkinen PJ: Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease. Neurobiol Aging 1988;9:245-252.
9. 3H-imipramine binding and monoamine oxidase B activity in Alzheimer's disease. J Neural Transm (P-D sect) 1990;2:139-147.
10. Sparks DL, Woeltz VM, Markesbery WR: Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease, and Pick's disease. Arch Neurol 1991;48:718-721.
11. 12 in dementia. Biol Psychiatry 1994;35:772-774.
12. Nakamura S, Kawamata T, Akiguchi I, Kameyama M, Nakamura N, Kimura H: Expression of monoamine oxidase B activity in astrocytes of senile plaques. Acta Neuropathol 1990; 80:419-425.
13. Jossan SS, Gillberg PG, Gottfries CG, Karlsson I, Oreland L: Monoamine oxidase B in brains from patients with Alzheimer's disease: A biochemical and autoradiographical study. Neuroscience 1991;45:1-12.
14. Saura J, Luque JM, Cesura AM, De Prada M, Chan-Palay V, Huber G, Löffler J, Richards JG: Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 1994;62:15-30.
15. Riederer P, Youdim MBH: The therapeutic place and value of present and future MAO-B inhibitors-L-deprenyl as the gold standard; in Szelenyi J (ed): Inhibitors of Monoamine Oxidase B, Pharmacology and Clinical Use in Neurodegenerative Disorders. Basel, Birkhäuser, 1993, pp 327-338.
16. Götz ME, Künig G, Riederer P, Youdim MBH: Oxidative stress: Free radical production in neural degeneration. Pharmacol Ther 1994;63:37-122.
17. Tariot PN, Schneider LS, Patel SV, Goldstein B: Alzheimer's disease and L-deprenyl: rationales and findings; in Szelenyi I (ed): Inhibitors of Monoamine Oxidase B. Pharmacology and Clinical Use in Neurodegenerative Disorders. Basel, Birkhäuser, 1993, pp 301-317.
18. Da Prada M: New approaches to the treatment of age-related brain disorders. Can J Neurol Sci 1991;18:384-386.
19. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, American Psychiatric Press, 1987.
20. McKhann G, Drachman D, Folstein M: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
21. Fischer P, Simanyi M, Danielczyk W: Depression in dementia of the Alzheimer type and in multi-infarct dementia. Am J Psychiatry 1990; 147:1484-1487.
22. Folstein MF, Folstein SE, McHugh PR: 'Mini-Mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
23. Koide Y, Koide N, Ross S, Sääf J, Wetterberg L: Monoamine oxidase in human platelets: Kinetics and methodological aspects. Biochem Pharmacol 1981;30:2893-2900.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
25. Wurtman RJ, Axelrod J: A sensitive and specific assay for the estimation of monoamine oxidase. Biochem Pharmacol 1963;12:1439-1441.
26. Tipton KF, Youdim MBH: Assay of monoamine oxidase; in Wolstenholme GEW, Knight J (eds): Monoamine Oxidase and Its Inhibition. Amsterdam, North-Holland/Excerpta Medica, 1976, pp 393-403.
27. Tipton KF, Youdim MBH: The assay of monoamine oxidase; in Parvez S, Nagatsu T, Nagatsu I, Parvez H (eds): Methods in Biogenic Amine Research. Amsterdam. Elsevier, 1983, pp 441-465.
28. Yu PH: Monoamine Oxidase; in Boulton AA, Baker GB, Yu PH (eds): Neuromethods. Clifton, Humana Press, 1986, vol 5, pp 235-272.
29. Tipton KF, Singer TP: The biochemical assay for monoamine oxidase activity: Problems and pitfalls. Biochem Pharmacol 1993;46:1311-1316.
30. Krueger MJ, Singer TP: An examination of the reliability of the radiochemical assay for monoamine oxidases A and B. Anal Biochem 1993; 214:116-123.
31. Shih JC, Chen K, Grimsby JS, Zhu Q-S, Gallaher TK: Structure, gene, and promoter organization of monoamine oxidases A and B; in Lieberman A, Olanow CW, Youdim MBH, Tipton K (eds): Monoamine Oxidase Inhibitors in Neurological Diseases. New York, Marcel Dekker, 1994, pp 77-94.
32. Breakefield XO, Chen ZY, Tivol E, Shalish C: Molecular genetics and inheritance of human monoamine oxidases A and B; in Lieberman A, Olanow CW, Youdim MBH, Tipton K (eds): Monoamine Oxidase Inhibitors in Neurological Diseases. New York, Marcel Dekker, 1994, pp 95-112.
33. Oxenstierna G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G: Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals: A genetic study. J Psychiatr Res 1986;20:19-29.
34. Pandey GN, Dorus E, Shaughnessy R, Davis JM: Genetic control of platelet monoamine oxidase activity: studies on normal families. Life Sci 1979;25:1173-1178.
35. Glover V, Sandler M, Hughes A, Hoffbrand AV: Platelet monoamine oxidase activity in megaloblastic anaemia. J Clin Pathol 1980;33: 963-965.
36. 12 levels related to high activity of platelet MAO in patients with dementia disorders. Acta Psychiatr Scand 1988;78:451-457.
37. 12-induced reduction of platelet monoamine oxidase activity in patients with dementia and pernicious anaemia. Eur Arch Psychiatry Clin Neurosci 1991;240:288-291.